Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
Change in Working Capital
Redhill Biopharma Ltd
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Change in Working Capital
-$3.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Change in Working Capital
-$206m
|
CAGR 3-Years
57%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Change in Working Capital
$28.1m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Change in Working Capital
-₪98.8m
|
CAGR 3-Years
-186%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-55%
|
Mediwound Ltd
NASDAQ:MDWD
|
Change in Working Capital
$2.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Change in Working Capital
₪4.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Redhill Biopharma Ltd's Change in Working Capital?
Change in Working Capital
-3.8m
USD
Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Change in Working Capital amounts to -3.8m USD.